JP2022548071A5 - - Google Patents
Info
- Publication number
- JP2022548071A5 JP2022548071A5 JP2022516237A JP2022516237A JP2022548071A5 JP 2022548071 A5 JP2022548071 A5 JP 2022548071A5 JP 2022516237 A JP2022516237 A JP 2022516237A JP 2022516237 A JP2022516237 A JP 2022516237A JP 2022548071 A5 JP2022548071 A5 JP 2022548071A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- metformin
- retinal
- acceptable salt
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962899899P | 2019-09-13 | 2019-09-13 | |
| US62/899,899 | 2019-09-13 | ||
| PCT/US2020/050540 WO2021050980A1 (en) | 2019-09-13 | 2020-09-11 | Druggable target to treat retinal degeneration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022548071A JP2022548071A (ja) | 2022-11-16 |
| JP2022548071A5 true JP2022548071A5 (https=) | 2023-09-20 |
Family
ID=72644998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516237A Pending JP2022548071A (ja) | 2019-09-13 | 2020-09-11 | 網膜変性を治療するための新薬の開発につながる標的 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220339127A1 (https=) |
| EP (1) | EP4027985A1 (https=) |
| JP (1) | JP2022548071A (https=) |
| KR (1) | KR20220070232A (https=) |
| CN (1) | CN114650813A (https=) |
| AU (1) | AU2020346064A1 (https=) |
| BR (1) | BR112022004515A2 (https=) |
| CA (1) | CA3151011A1 (https=) |
| MX (1) | MX2022003027A (https=) |
| WO (1) | WO2021050980A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7505912B2 (ja) * | 2020-04-30 | 2024-06-25 | 小林製薬株式会社 | オートファジー活性化剤 |
| WO2022023956A1 (en) * | 2020-07-31 | 2022-02-03 | The Joan and Irwin Jacobs Technion-Cornell Institute | System and method for on-phase microscopy |
| KR102629963B1 (ko) * | 2021-09-23 | 2024-01-29 | 순천향대학교 산학협력단 | mTOR 활성화제를 포함하는 안질환 치료용 조성물 및 이의 용도 |
| CN115969844B (zh) * | 2021-12-28 | 2024-04-02 | 首都医科大学附属北京同仁医院 | Nox2特异性抑制剂在制备视网膜变性药物中的应用 |
| US20250170143A1 (en) * | 2022-04-14 | 2025-05-29 | Mayo Foundation For Medical Education And Research | Methods of treating ocular fibrotic pathologies |
| CN115068456A (zh) * | 2022-05-18 | 2022-09-20 | 中山大学中山眼科中心 | 二甲双胍在制备预防、治疗眼部疾病的药物中的用途及其剂型和制备方法 |
| WO2023229993A1 (en) * | 2022-05-25 | 2023-11-30 | Curative Biotechnology, Inc. | Ophthalmic formulation capable of delivering metformin to choroid rpe and retina |
| KR20230169735A (ko) | 2022-06-09 | 2023-12-18 | 에스케이온 주식회사 | 배터리용 볼트 및 배터리 모듈 |
| WO2024196814A1 (en) | 2023-03-17 | 2024-09-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods for treatment of age-related macular degeneration |
| EP4559900A1 (en) * | 2023-11-21 | 2025-05-28 | Opus Genetics, Inc. | Phentolamine mesylate and therapeutic uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| CN1704048A (zh) * | 2004-05-25 | 2005-12-07 | 孙明杰 | 复方羟苯磺酸钙 |
| US20060257391A1 (en) * | 2005-05-11 | 2006-11-16 | Bausch & Lomb Incorporated | Non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions |
| WO2008022256A2 (en) * | 2006-08-16 | 2008-02-21 | Blagosklonny Mikhail V | Methods and compositions for preventing or treating age-related diseases |
| JP2010047567A (ja) * | 2008-07-24 | 2010-03-04 | Santen Pharmaceut Co Ltd | 加齢黄斑変性の予防又は治療剤 |
| KR101498665B1 (ko) * | 2013-01-10 | 2015-03-05 | 한국 한의학 연구원 | 천연 추출물을 포함하는 당뇨합병증 또는 혈관부종의 예방 또는 치료용 약학적 조성물 및 건강기능식품 조성물 |
| WO2014152661A1 (en) * | 2013-03-14 | 2014-09-25 | Panoptica, Inc. | Ocular formulations for drug-delivery to the posterior segment of the eye |
| WO2015103480A1 (en) * | 2014-01-02 | 2015-07-09 | Massachusetts Eye & Ear Infirmary | Treating ocular neovascularization |
| CA2976632A1 (en) * | 2015-02-13 | 2016-08-18 | Stealth Biotherapeutics Corp | Therapeutic compositions including mitochondrial fission inhibitor peptides, variants thereof and methods of using the same |
| US20200056186A1 (en) * | 2016-09-22 | 2020-02-20 | Rsem, Limited Partnership | Compositions comprising sasp modulators and senescence attenuators and uses thereof for modulating cellular senescence |
| WO2019033119A1 (en) * | 2017-08-11 | 2019-02-14 | Unity Biotechnology, Inc. | TREATMENT OF OPHTHALMIC CONDITIONS SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLS |
| WO2019108602A1 (en) * | 2017-11-28 | 2019-06-06 | University Of Florida Research Foundation | Methods and compositions for retinal drug delivery |
-
2020
- 2020-09-11 MX MX2022003027A patent/MX2022003027A/es unknown
- 2020-09-11 KR KR1020227012050A patent/KR20220070232A/ko not_active Ceased
- 2020-09-11 CA CA3151011A patent/CA3151011A1/en active Pending
- 2020-09-11 US US17/642,610 patent/US20220339127A1/en active Pending
- 2020-09-11 WO PCT/US2020/050540 patent/WO2021050980A1/en not_active Ceased
- 2020-09-11 EP EP20780525.0A patent/EP4027985A1/en active Pending
- 2020-09-11 AU AU2020346064A patent/AU2020346064A1/en active Pending
- 2020-09-11 BR BR112022004515A patent/BR112022004515A2/pt unknown
- 2020-09-11 JP JP2022516237A patent/JP2022548071A/ja active Pending
- 2020-09-11 CN CN202080075532.5A patent/CN114650813A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022548071A5 (https=) | ||
| JP7519413B2 (ja) | 眼科用薬剤組成物、眼科用キット、及びその医学的応用 | |
| PL211870B1 (pl) | Zastosowanie roflumilastu i jego pochodnych w leczeniu zespołu suchego oka oraz oftalmologiczny preparat farmaceutyczny w postaci kropli do oczu | |
| Abadia et al. | Clinical applications of dexamethasone for aged eyes | |
| JP2011500568A (ja) | 眼病治療のための組成物及び方法 | |
| JP2009501797A5 (https=) | ||
| CN111372576A (zh) | 用于治疗眼部病症的组合物和方法 | |
| JP2021519753A5 (https=) | ||
| RU2017112930A (ru) | Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза | |
| JP2022525007A5 (https=) | ||
| Khan et al. | Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders | |
| JP2003522160A5 (https=) | ||
| US20180207091A1 (en) | Novel methods for delivering therapeutic agents to the eye via nasal passages | |
| FI3720428T3 (fi) | Dobesiliinihappoa käsittävä oftalminen paikalliskoostumus silmän takasegmentin sairauksien hoitoon | |
| CN111315369A (zh) | 用于治疗眼部病症和皮肤疾病的化合物、组合物和方法 | |
| CN106999452B (zh) | 前列腺素类和一氧化氮供体的组合产品 | |
| JP2011518875A5 (https=) | ||
| WO2007075720A8 (en) | Topical mecamylamine formulations for ocular administration and uses thereof | |
| JP2013513606A5 (https=) | ||
| Basu et al. | Modified thiomer-based nanomedicines in management of ocular complications: a review | |
| JP7829678B2 (ja) | 神経変性眼疾患を治療するためのプリドピジン及びその類似体 | |
| TW202034918A (zh) | 治療眼睛病況之方法及組合物 | |
| JP2005515992A5 (https=) | ||
| JP2025511845A5 (https=) | ||
| Natesan et al. | Chitosan-based ocular drug delivery systems |